A phase I/II clinical study of intravenous administration of JR-171, a blood-brain barrier-crossing enzyme, in mucopolysaccharidosis type I: An updateTakashi Hamazaki,Satoshi Kawashima,Toshiaki Ikeda, Marin Noda,Sairei So,Kazunori Tanizawa,Yuji SatoMOLECULAR GENETICS AND METABOLISM（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
